News | December 20, 2025
Pfizer and Cipla forge exclusive marketing and distribution pact for key brands in India
This marks the first partnership between Pfizer and Cipla in India
This marks the first partnership between Pfizer and Cipla in India
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
Subscribe To Our Newsletter & Stay Updated
